false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Onconep ...
Update on Paraproteinemia and Kidney Pathologies: ...
Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Lihong Bu reviewed kidney lesions associated with monoclonal gammopathies, emphasizing that diagnosis of monoclonal gammopathy of renal significance (MGRS) requires collaboration between nephrologists and pathologists because deposits and underlying clones may be subtle or undetectable. She focused on proliferative glomerulonephritis with immunoglobulin deposits (PGNMID), which can involve IgG, IgA, IgM, or light chains. IgG3-kappa is the most common variant, but clone detection is often low. Recent research using sensitive light-chain variable-region staining and bone-marrow RNA sequencing showed that some deposits previously considered monoclonal are oligoclonal or polyclonal. Accordingly, pathologists should generally describe biopsy findings as <strong>monotypic</strong>; “monoclonal” should be used when a matching clone or protein is demonstrated. The findings may prompt similar terminology changes for other lesions, including membranous nephropathy. Bu concluded that biopsy remains essential, while understanding and classification of MGRS lesions continue to evolve.
Asset Caption
Lihong Bu, MD, PhD
Meta Tag
Speaker
Lihong Bu
Keywords
monoclonal gammopathy of renal significance
MGRS
proliferative glomerulonephritis with immunoglobulin deposits
PGNMID
IgG3-kappa
kidney biopsy
×
Please select your language
1
English